Welcome to LookChem.com Sign In|Join Free
  • or
"2H-1,4-Benzodiazepin-2-one, 7-bromo-1,3-dihydro-5-phenyl-, 4-oxide" is a complex organic compound belonging to the benzodiazepine class. It is characterized by a benzodiazepine core structure, which is a fused ring system consisting of a diazepine (a seven-membered ring with two nitrogen atoms) and a benzene ring. This particular compound features a 7-bromo substitution, indicating the presence of a bromine atom at the 7th position of the benzodiazepine ring. Additionally, it has a 1,3-dihydro and 5-phenyl group, which means it has two hydrogen atoms attached to the 1st and 3rd positions and a phenyl group (a benzene ring) at the 5th position. The 4-oxide notation suggests that there is an oxygen atom incorporated into the structure, likely as part of an oxide functional group. 2H-1,4-Benzodiazepin-2-one, 7-bromo-1,3-dihydro-5-phenyl-, 4-oxide may have potential applications in pharmaceuticals or as a chemical intermediate, but its specific uses and properties would depend on further research and characterization.

2893-99-4

Post Buying Request

2893-99-4 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

2893-99-4 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 2893-99-4 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 2,8,9 and 3 respectively; the second part has 2 digits, 9 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 2893-99:
(6*2)+(5*8)+(4*9)+(3*3)+(2*9)+(1*9)=124
124 % 10 = 4
So 2893-99-4 is a valid CAS Registry Number.

2893-99-4SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name 7-bromo-4-oxy-5-phenyl-1,3-dihydro-benzo[e][1,4]diazepin-2-one

1.2 Other means of identification

Product number -
Other names 7-bromo-1,3-dihydro-5-phenyl-2H-1,4-benzodiazepin-2-one 4-oxide

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:2893-99-4 SDS

2893-99-4Relevant academic research and scientific papers

SELECTIVE ANTICONVULSANT AGENTS AND THEIR USES

-

, (2010/11/03)

In preferred embodiments, the present invention provides methods of treatment and pharmaceutical compositions for the suppression, alleviation and prevention of seizures. The preferred embodiments of the present invention further relate to methods of treatment and pharmaceutical compositions using benzodiazepine derivatives that provide suppression, alleviation and prevention of seizures with reduced sedative and ataxic side effects.

Stereospecific anxiolytic and anticonvulsant agents with reduced muscle-relaxant, sedative-hypnotic and ataxic effects

-

Page/Page column 47-48, (2008/06/13)

The present invention provides compositions and methods of using stereospecific benzodiazepine derivatives, their salts and prodrugs for the treatment of anxiolytic or convulsant disorders having the side effects of reduced alcohol craving in human alcoholics and a concomitant reduced sedative, hypnotic, muscle relaxant and ataxic side-effects. The invention further provides pharmaceutical compositions for treatment of anxiolytic and convulsant disorders in subjects in need thereof, comprising a compound, prodrug or a salt having a chemical structure represented by any one of Formula I-XXI and a pharmaceutically-acceptable carrier.

ANXIOLYTIC AGENTS WITH REDUCED SEDATIVE AND ATAXIC EFFECTS

-

Page/Page column 79; 80, (2010/02/07)

Orally active benzodiazepine derivatives and their salts are disclosed. These compounds and their salts have anxiolytic and anticonvulsant activity with reduced sedative/hypnotic/muscle relaxant/ataxic effects.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 2893-99-4